D. Cohen

发表

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.

K. Anstrom, G. Fonarow, C. Cannon, 2019, JAMA cardiology.

ST-segment elevation myocardial infarction

Hugo A. Katus, Hiroki Shiomi, Birgit Vogel, 2019, Nature Reviews Disease Primers.

Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry

Sunil V. Rao, A. Kirtane, R. Yeh, 2019, JAMA cardiology.

Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and

K. Anstrom, J. Messenger, E. Peterson, 2016, Circulation. Cardiovascular interventions.

Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.

K. Anstrom, C. Cannon, T. Henry, 2016, American heart journal.

In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study

K. Anstrom, J. Messenger, A. Bagai, 2015, European heart journal. Acute cardiovascular care.

Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

J. Spertus, S. Arnold, D. Cohen, 2015, Journal of the American College of Cardiology.

Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.

David J Cohen, D. Cohen, K. Kennedy, 2015, JACC. Cardiovascular interventions.

Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?

S. Rathore, L. Mauri, R. Yeh, 2014, American heart journal.

Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE‐ACS) obse

K. Anstrom, J. Messenger, T. Henry, 2017, American heart journal.

K. Anstrom, C. Cannon, T. Henry, 2016, American heart journal.

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

J. Ware, S. Pocock, H. White, 2007, JAMA.

Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy

David P Miller, E. Antman, C. Cannon, 2006, Circulation.

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

Deepak L. Bhatt, C. Cannon, W. Gibler, 2005, JAMA.

Predicting Likelihood for Coronary Artery Bypass Grafting After Non-ST-Elevation Myocardial Infarction: Finding the Best Prediction Model.

J. Spertus, D. Cohen, Jae-Sik Jang, 2016, The Annals of thoracic surgery.

Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction

Nicholas Moore, Harry Hemingway, Spiros C. Denaxas, 2016, European heart journal. Quality of care & clinical outcomes.

Heparin Monotherapy or Bivalirudin During Percutaneous Coronary Intervention in Patients With Non–ST-Segment–Elevation Acute Coronary Syndromes or Stable Ischemic Heart Disease: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry

M. Pencina, S. Bangalore, N. Kleiman, 2014, Circulation. Cardiovascular Interventions.

Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.

N. Kleiman, D. Cohen, K. Kennedy, 2011, American heart journal.

Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.

W. Gibler, E. Ohman, E. Peterson, 2009, American Journal of Cardiology.

Vision and Creation of the American Heart Association Pharmaceutical Roundtable Outcomes Research Centers

A. Go, J. Spertus, E. Peterson, 2009, Circulation. Cardiovascular quality and outcomes.

A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.

R. Ferrari, M. Valgimigli, D. Cohen, 2008, International journal of cardiology.

Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes.

E. Ohman, E. Peterson, D. Magid, 2007, Circulation.

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.

F. Prati, R. Ferrari, M. Valgimigli, 2007, American heart journal.

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry

Harlan M. Krumholz, John C. Messenger, Richard G. Bach, 2006, Circulation.

Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

W. Gibler, E. Ohman, Sidney C. Smith, 2005, The American journal of cardiology.

Relationship of Albuminuria and Renal Artery Stent OutcomesNovelty and Significance

R. D'Agostino, J. Massaro, S. Textor, 2016 .

The association between blood pressure and mortality in patients with heart failure.

David J Cohen, Jersey Chen, D. Cohen, 2006, American heart journal.

Coronary artery stenting in the aged.

D. Baim, J. Popma, D. Cohen, 2001, Journal of the American College of Cardiology.

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2017, Journal of the American College of Cardiology.

Incidence ,

S. Pocock, T. Henry, M. Krucoff, 2018 .

Randomized, multicenter trial comparing sternotomy closure with rigid plate fixation to wire cerclage

D. Cohen, V. Thourani, K. Allen, 2017, The Journal of thoracic and cardiovascular surgery.

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

P. Serruys, M. Krucoff, S. Windecker, 2007, Circulation.

Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.

Victor A. Rodriguez, G. Tison, A. Einstein, 2022, Journal of the American College of Cardiology.

Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients

J. Leipsic, S. Pocock, M. Mack, 2019, The New England journal of medicine.

Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

Sean M. O'Brien, F. Grover, E. Peterson, 2018, JACC. Cardiovascular interventions.

Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Sean M. O'Brien, J. Rumsfeld, E. Peterson, 2016, Circulation. Cardiovascular quality and outcomes.

Identification of Frailty Using a Claims‐Based Frailty Index in the CoreValve Studies: Findings from the EXTEND‐FRAILTY Study

J. Spertus, R. Gerszten, R. Yeh, 2021, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement

J. Spertus, R. Gerszten, R. Yeh, 2021, Circulation. Cardiovascular quality and outcomes.

Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries

R. Yeh, J. Popma, D. Cohen, 2018, Circulation. Cardiovascular quality and outcomes.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Braunwald, S. Normand, E. Braunwald, 2014, The New England journal of medicine.

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

H. Diener, W. Hacke, R. Jahan, 2015, The New England journal of medicine.

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

M. Mack, E. Tuzcu, L. Svensson, 2016, The New England journal of medicine.

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents.

J. Granada, M. Parikh, N. Kleiman, 2007, JAMA.

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

M. Dake, W. O’Neill, D. Wood, 2019, Circulation. Cardiovascular interventions.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Pascal Vranckx, Susheel Kodali, Patrick W Serruys, 2012, Journal of the American College of Cardiology.

Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial

P. Teirstein, M. Leon, D. Cohen, 2002, Circulation.

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

D. Scheinert, M. Jaff, P. Krishnan, 2015, Circulation.

Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.

Samin K. Sharma, P. Dehghani, T. Henry, 2022, JACC. Cardiovascular interventions.

Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

J. Massaro, E. Mohler, J. Regensteiner, 2015, Journal of the American College of Cardiology.

Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study

J. Ehrman, J. Massaro, E. Mohler, 2012, Circulation.

Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Michael D Hill, George Howard, Stanley N Cohen, 2010, The New England journal of medicine.

Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.

S. Pocock, T. Henry, M. Krucoff, 2016, JACC. Cardiovascular interventions.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

A. Jacobs, S. Windecker, J. Massaro, 2015, Journal of the American College of Cardiology.

Very early changes in quality of life after transcatheter aortic valve replacement: Results from the 3M TAVR trial.

D. Wood, S. Lauck, J. Webb, 2020, Cardiovascular revascularization medicine : including molecular interventions.

THE IMPACT OF SIX–MINUTE WALK TEST PERFORMANCE ON OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL

M. Mack, A. Kirtane, M. Leon, 2013 .

Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.

Samin K. Sharma, S. Pocock, E. Ohman, 2020, European heart journal.

Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

K. Anstrom, C. Cannon, T. Henry, 2019, JAMA.

Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronar

K. Anstrom, G. Stone, A. Bagai, 2017, American heart journal.

Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.

S. Pocock, E. Ohman, M. Krucoff, 2016, American heart journal.

Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction

J. Spertus, D. Cohen, J. Valle, 2016, Journal of the American Heart Association.

Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.

J. Messenger, T. Henry, E. Peterson, 2015, American heart journal.

Cluster-Randomized Clinical Trial Examining the Impact of Platelet Function Testing on Practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Prospective Open Label Antiplatelet Therapy Study

K. Anstrom, T. Henry, E. Peterson, 2015, Circulation. Cardiovascular interventions.

Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.

John A Spertus, David J Cohen, John S Rumsfeld, 2010, JAMA.

Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.

K. Alexander, W. Gibler, E. Ohman, 2007, Journal of the American College of Cardiology.

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

E. Topol, G. Stone, C. Grines, 2001, The New England journal of medicine.

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

Antonio Colombo, Mitchell W Krucoff, George Dangas, 2013, The Lancet.

Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level

Milton C. Weinstein, Krisela Steyn, Lionel H. Opie, 2005, Circulation.

Versus Blood Pressure Level Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa : Absolute Risk

M. Weinstein, L. Opie, D. Cohen, 2005 .

Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI

Irina Proskorovsky, David J. Cohen, Elizabeth M. Mahoney, 2010, Circulation.

Improvements in Symptoms and Quality of Life in Patients With Paroxysmal Atrial Fibrillation Treated With Radiofrequency Catheter Ablation Versus Antiarrhythmic Drugs

D. Cohen, M. Reynolds, D. Wilber, 2010, Circulation. Cardiovascular quality and outcomes.

Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

David J Cohen, Mark E Josephson, M. Josephson, 2009, Circulation. Arrhythmia and electrophysiology.

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.

P. Zimetbaum, T. Lavelle, D. Cohen, 2006, American heart journal.

When is better not good enough?: Insights from the COURAGE economic study.

A. Kirtane, D. Cohen, D. Cohen, 2008, Circulation. Cardiovascular quality and outcomes.

When Is Better Not Good Enough ?

A. Kirtane, D. Cohen, D. Cohen, 2008 .

Insights From the COURAGE Economic Study

A. Kirtane, D. Cohen, D. Cohen, 2008 .

Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.

J. Piccini, A. Kirtane, E. Peterson, 2018, JACC. Cardiovascular interventions.

Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.

Christopher J O'Donnell, Robert M Califf, Matthew J Price, 2012, Circulation.

on a National Heart, Lung and Blood Institute Working Group Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report

Deepak L. Bhatt, V. Fuster, R. Califf, 2014 .

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).

T. Ryan, L. Räber, A. Kirtane, 2014, JACC. Cardiovascular interventions.

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

S. Pocock, G. Stone, T. Henry, 2016, Journal of the American College of Cardiology.

Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.

E. Peterson, R. Bach, M. Effron, 2016, Journal of the American College of Cardiology.

Impact of Short-Term Complications of TAVR on Longer-Term Outcomes: Results from the STS/ACC Transcatheter Valve Therapy Registry.

J. Carroll, M. Mack, J. Bavaria, 2020, European heart journal. Quality of care & clinical outcomes.

Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial).

M. Mack, F. Welt, M. Leon, 2016, The American journal of cardiology.

Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.

M. Mack, M. Leon, J. Webb, 2014, Journal of the American College of Cardiology.

Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).

M. Mack, A. Kirtane, L. Svensson, 2014, Journal of the American College of Cardiology.

Incidence, Predictors, and PrognosticImpact of Late Bleeding Complications After Transcatheter Aortic Valve Replacement

M. Mack, M. Leon, J. Webb, 2022 .

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Ralph B D'Agostino, Martin R Prince, David J Cohen, 2014, The New England journal of medicine.

Association between bleeding events and in-hospital mortality after percutaneous coronary intervention.

David J Cohen, J. Messenger, D. Cohen, 2013, JAMA.

Vascular closure devices: the second decade.

H. Dauerman, D. Cohen, R. Applegate, 2007, Journal of the American College of Cardiology.

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

R. Califf, C. Buller, W. Cantor, 2002, JAMA.

Transcatheter Mitral‐Valve Repair in Patients with Heart Failure

M. Mack, G. Stone, N. Weissman, 2018, The New England journal of medicine.

TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial.

M. Mack, A. Kirtane, T. Nazif, 2016, Journal of the American College of Cardiology.

Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.

J. Leipsic, M. Mack, T. Nazif, 2021, European heart journal.

Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

J. Leipsic, M. Mack, N. Weissman, 2016, The Lancet.

The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.

Jeroen J. Bax, J. Leipsic, W. O’Neill, 2022, JACC. Cardiovascular interventions.

Intravenous Acetaminophen Improves Outcomes After Transapical Transcatheter Aortic Valve Replacement

D. Cohen, K. Allen, A. Michael Borkon, 2018, Innovations.

Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy

L. Svensson, M. Leon, P. Douglas, 2018 .

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, The Journal of thoracic and cardiovascular surgery.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, Journal of the American College of Cardiology.

Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation

David J Cohen, Brett G. Sylvia, A. Jeremias, 2004, Circulation.

Cost Estimation of Cardiovascular Disease Events in the US

David Thompson, David J. Cohen, Amy K. O’Sullivan, 2011, PharmacoEconomics.

Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States

Deepak L. Bhatt, S. Duval, E. Mahoney, 2010, Circulation. Cardiovascular quality and outcomes.

Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes.

Neel M. Butala, A. Kosinski, R. Yeh, 2020, JACC. Cardiovascular interventions.

Long-Term Clinical Outcomes After Unprotected Left Main Trunk Percutaneous Revascularization in 279 Patients

Seung‐Jung Park, S. Ellis, M. Nobuyoshi, 2001, Circulation.

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.

R. Hendel, R. Bonow, J. Moses, 2005, Journal of the American College of Cardiology.

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

Hong Wang, D. Scheinert, M. Jaff, 2015, Journal of the American College of Cardiology.

Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study

W. Gray, M. Jaff, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous Coronary Revascularization in Elderly Patients: Impact on Functional Status and Quality of Life

T. Seto, D. Cohen, K. Ho, 2000, Annals of Internal Medicine.

The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.

D. Cohen, M. Reynolds, S. Culler, 2008, The Annals of thoracic surgery.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Samin K. Sharma, S. Pocock, E. Ohman, 2019, The New England journal of medicine.

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)

S. Pocock, Binita Shah, T. Henry, 2017, Circulation. Cardiovascular interventions.

Percutaneous Coronary Intervention: Finally Mature Enough.

D. Cohen, S. Rinfret, S. Baron, 2015, Journal of the American College of Cardiology.

Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention.

Samin K. Sharma, S. Pocock, G. Dangas, 2020, Journal of the American College of Cardiology.

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent

M. Pencina, S. Normand, J. Massaro, 2010, American heart journal.

Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina

J. Spertus, J. Moses, D. Cohen, 2019, Circulation. Cardiovascular interventions.

Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention

S. Normand, J. Spertus, L. Mauri, 2011, Circulation.

Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the Placement of Aortic Transcatheter Valves Trial and Registries

I. Palacios, D. Kolte, M. Leon, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.

Jeroen J. Bax, J. Leipsic, M. Mack, 2021, Journal of the American College of Cardiology.

Age and Outcomes After Carotid Stenting and Endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial

T. Brott, G. Howard, B. Lal, 2011, Stroke.

Trial of everolimus-eluting stents or bypass surgery for coronary disease.

A. Yeung, M. Jeong, K. Seung, 2015, The New England journal of medicine.

Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status.

K. Alexander, J. Spertus, R. Bach, 2013, Journal of the American College of Cardiology.

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

J. Spertus, J. Rumsfeld, D. Cohen, 2009, JACC. Cardiovascular interventions.

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study

E. Peterson, G. Fonarow, M. Effron, 2017, Journal of the American Heart Association.

Impact of calcification on percutaneous coronary intervention: MACE‐Trial 1‐year results

Manesh R. Patel, Samin K. Sharma, R. Mehran, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.

S. Pocock, T. Henry, M. Krucoff, 2019, American Journal of Cardiology.

Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.

S. Pocock, T. Henry, G. Dangas, 2017, International journal of cardiology.

Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).

S. Pocock, T. Henry, G. Dangas, 2017, The American journal of cardiology.

Predicting long‐term bleeding after percutaneous coronary intervention

J. Spertus, R. Bach, S. Arnold, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.

Deepak L. Bhatt, J. Spertus, Darren K Mcguire, 2016, American heart journal.

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry

S. Pocock, T. Henry, G. Dangas, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.

J. Messenger, G. Stone, E. Peterson, 2015, JACC. Cardiovascular interventions.

The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes.

R. Yeh, D. Cohen, S. Baron, 2014, Circulation.

No "i" in Heart Team: incentivizing multidisciplinary care in cardiovascular medicine.

B. Nallamothu, D. Cohen, D. Cohen, 2012, Circulation. Cardiovascular quality and outcomes.

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study

R. D'Agostino, C. Cannon, J. Massaro, 2017, JAMA cardiology.

Comparison of procedural complications with versus without interventional cardiology fellows-in-training during contemporary percutaneous coronary intervention.

D. Cohen, K. Kennedy, S. Marso, 2014, The American journal of cardiology.

Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice: Derivation and Validation of a Risk Model From the EVENT Registry

M. Pencina, L. Mauri, N. Kleiman, 2010, Circulation. Cardiovascular interventions.

Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials

D. Baim, J. Massaro, D. Cohen, 2004, Circulation.

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

E. Topol, W. Desmet, P. D. de Feyter, 2004, JAMA.

Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial

Ameet Bakhai, Chunxue Shi, Tara Lavelle, 2004, Circulation.

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

E. Topol, W. Desmet, P. D. de Feyter, 2003, JAMA.

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.

D. Baim, J. Popma, D. Cohen, 2002, Journal of the American College of Cardiology.

Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial*

E. Topol, G. Stone, C. Grines, 2002, Circulation.

Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials

D. Baim, A. Lansky, J. Popma, 2001, Circulation.

Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

D. Baim, D. Cohen, C. Gibson, 1994, Circulation.

Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry

P. Zimetbaum, D. Cohen, M. Reynolds, 2007, Journal of cardiovascular electrophysiology.

Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

V. Fuster, M. Domanski, G. Dangas, 2008, American heart journal.

Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems.

D. Baim, D. Cohen, R. Kuntz, 1996, Journal of the American College of Cardiology.

Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis.

H. Dauerman, D. Baim, D. Cohen, 1998, The American journal of cardiology.

Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

J. Massaro, E. Mohler, J. Regensteiner, 2013, Journal of vascular and interventional radiology : JVIR.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).

M. Mack, P. Serruys, A. Kirtane, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States

Deepak L. Bhatt, Deepak L Bhatt, David J Cohen, 2008, Circulation. Cardiovascular quality and outcomes.

Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.

S. Kapadia, A. Kosinski, D. Cohen, 2020, American heart journal.

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Sean M. O'Brien, J. Carroll, M. Mack, 2019, The Annals of thoracic surgery.

Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison.

Sean M. O'Brien, M. Pencina, M. Mack, 2017, Journal of the American College of Cardiology.

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.

D. Adams, J. Spertus, J. Afilalo, 2016, Journal of the American College of Cardiology.

Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial

M. Mack, A. Kirtane, M. Leon, 2014, Circulation.

The Norwood operation: Relative effects of surgeon and institutional volumes on outcomes and resource utilization

E. Bacha, D. Cohen, W. Lai, 2015, Cardiology in the Young.

Repeat Revascularization After Contemporary Percutaneous Coronary Intervention: An Evaluation of Staged, Target Lesion, and Other Unplanned Revascularization Procedures During the First Year

Michael J Pencina, Laura Mauri, David J Cohen, 2012, Circulation. Cardiovascular interventions.

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease

Navdeep K. Bhatti, G. Stone, A. Kirtane, 2016, Journal of the American Heart Association.

ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures

E. DeLong, R. Hendel, D. Goff, 2011, Circulation.

ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.

E. DeLong, R. Hendel, R. Bonow, 2011, Journal of the American College of Cardiology.

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke

H. Diener, W. Hacke, V. Reddy, 2015, International journal of stroke : official journal of the International Stroke Society.

Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin‐induced thrombocytopenia

D. Cohen, D. Pinto, J. Carrozza, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not "All About the Benjamins".

D. Cohen, Khanjan B Shah, Khanjan B. Shah, 2021, Circulation. Cardiovascular quality and outcomes.

Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement

Neel M. Butala, A. Kosinski, R. Yeh, 2021, Circulation.

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial

M. Mack, L. Svensson, M. Leon, 2019, Circulation.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

D. Adams, C. Meduri, J. Popma, 2016, Journal of the American College of Cardiology.

Causes of late mortality with dual antiplatelet therapy after coronary stents.

R. D'Agostino, E. Braunwald, S. Windecker, 2015, European heart journal.

The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.

J. Leipsic, D. Wood, T. Nazif, 2019, JACC. Cardiovascular interventions.

Staging classification of aortic stenosis based on the extent of cardiac damage

M. Mack, E. Tuzcu, L. Svensson, 2017, European heart journal.

STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.

J. Carroll, M. Mack, J. Bavaria, 2020, Journal of the American College of Cardiology.

Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018

J. Bavaria, J. Giri, N. Desai, 2021, Circulation. Cardiovascular Quality and Outcomes.

A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.

E. Braunwald, P. Stone, D. Morrow, 2006, Journal of the American College of Cardiology.

Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

S. Goldhaber, M. Jaff, D. Cohen, 2013, American heart journal.

Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries.

R. Yeh, J. Popma, D. Cohen, 2019, American Journal of Cardiology.

Clinical and economic outcomes among elderly myocardial infarction survivors in the United States.

S. Johansson, D. Cohen, P. Hunt, 2016, Cardiovascular therapeutics.

Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.

M. Pencina, S. Steinhubl, A. Jeremias, 2010, JACC. Cardiovascular interventions.

Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns

Sunil V. Rao, S. Mehta, W. Cantor, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.

J. Spertus, M. Patterson, D. Cohen, 2017, JACC. Cardiovascular interventions.

Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST

T. Brott, G. Howard, R. Prineas, 2017, Circulation. Cardiovascular quality and outcomes.

Cost-Effectiveness of Percutaneous Coronary Interventions

D. Cohen, A. Bakhai, D. Cohen, 2003 .

Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.

S. Murphy, D. Baim, T. Lavelle, 2004, Journal of the American College of Cardiology.

A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).

Samin K. Sharma, D. Baim, A. Lansky, 2002, The American journal of cardiology.

Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial

G. Stone, C. Grines, M. Morice, 2001, Circulation.

Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial.

G. Stone, C. Grines, M. Morice, 2001, Journal of the American College of Cardiology.

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.

D. Baim, J. Popma, D. Cohen, 2001, American heart journal.

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial

J. J. Griffin, V. L. Clark, W. Weaver, 2000, The Lancet.

Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.

W. Weintraub, A. Kosinski, D. Cohen, 1999, Journal of the American College of Cardiology.

The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs.

D. Baim, D. Cohen, K. Ho, 1997, The American journal of cardiology.

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.

H. Krumholz, J. Moses, M. Savage, 1995, Circulation.

Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.

L. Goldman, M. Weinstein, D. Baim, 1994, Circulation.

In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.

G. Levine, J. Tcheng, D. Cohen, 2002, The American journal of cardiology.

W. Desmet, A. Lincoff, J. Bittl, 2006 .

Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.

A. Jeremias, S. Filardo, R. Whitbourn, 2000, American heart journal.

Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement

M. Mack, D. Wood, M. Leon, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Myocardial Infarction After Carotid Stenting and Endarterectomy: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial

J. Eidt, T. Brott, R. Prineas, 2011, Circulation.

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

D. Cohen, Gordon Liu, X. Qin, 2022, BMC Medicine.

Transcarotid Versus Transapical and Transaortic Access for Transcatheter Aortic Valve Replacement.

D. Cohen, K. Allen, A. Chhatriwalla, 2019, The Annals of thoracic surgery.

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting.

D. Baim, D. Cohen, M. Moscucci, 1994, The American journal of cardiology.

Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trial.

W. Weaver, J. Spertus, S. Ramsey, 2002, Journal of interventional cardiology.

Rotational atherectomy or balloon angioplasty in the treatment of intra‐stent restenosis: BARASTER Multicenter Registry

P. Teirstein, S. Goldberg, H. Dauerman, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses.

A. Jeremias, A. Yeung, P. Yock, 2000, The American journal of cardiology.

Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry

Sean M. O'Brien, M. Mack, J. Spertus, 2015, Circulation. Cardiovascular interventions.

Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation

P. Pibarot, D. Cohen, L. Nombela‐Franco, 2012, Heart.

Do the benefits of new technology outweigh the costs?

D. Cohen, A. Bakhai, Dan Gremberg, 2003 .

Effects of stent length and lesion length on coronary restenosis.

A. J. O’Malley, D. Baim, L. Mauri, 2004, The American journal of cardiology.

Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2016, JACC. Cardiovascular interventions.

Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures).

J. Spertus, J. Moses, R. Yeh, 2017, JACC. Cardiovascular interventions.

Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry

L. Allen, J. Spertus, S. Arnold, 2016, Circulation. Heart failure.

Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy

Sanjiv J. Shah, J. Spertus, M. Maurer, 2020, Circulation.

Troponin criteria for myocardial infarction after percutaneous coronary intervention.

M. Pencina, V. Novack, N. Kleiman, 2012, Archives of internal medicine.

Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

Deepak L. Bhatt, E. Ohman, Sidney C. Smith, 2012, Circulation.

Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation.

M. Josephson, L. Epstein, P. Zimetbaum, 1999, The American journal of cardiology.

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Michael T. McManus, Renan Sales Barros, Hester F. Lingsma, 2019, The Lancet Neurology.

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.

Renan Sales Barros, Hester F. Lingsma, Ivo G. H. Jansen, 2018, The Lancet. Neurology.

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

H. Diener, W. Hacke, R. Jahan, 2017, Stroke.

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

D. Mark, R. Giugliano, E. Braunwald, 2017, Circulation. Cardiovascular quality and outcomes.

Balloon angioplasty versus debulking for treatment of diffuse in-stent restenosis

H. Dauerman, D. Baim, C. Gibson, 1998 .

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

R. D'Agostino, M. Jaff, W. Henrich, 2006, American heart journal.

Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.

A. Berman, D. Baim, D. Cohen, 1997, American Journal of Cardiology.

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

R O Bonow, Atlanta, R. Bonow, 2000, Circulation.

Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.

M. Pencina, J. Spertus, N. Kleiman, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.

M. Mack, G. Stone, B. Whisenant, 2020, JACC. Cardiovascular interventions.

Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.

M. Mack, J. Spertus, G. Stone, 2019, Journal of the American College of Cardiology.

Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.

M. Mack, G. Stone, V. Rajagopal, 2020, Journal of the American College of Cardiology.

Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.

M. Mack, G. Stone, W. Abraham, 2020, Journal of the American College of Cardiology.

Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.

Jersey Chen, P. Chan, M. Fang, 2014, The American journal of managed care.

The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

D. Cohen, M. Reynolds, E. Becker, 2006, Journal of the American College of Cardiology.

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial

Seung‐Jung Park, S. Yun, Sang-Wook Lim, 2019, Circulation.

Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary Intervention: Another Smoker’s Paradox?

J. Popma, D. Cohen, D. Cutlip, 2001, Circulation.

Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative

Deepak L. Bhatt, C. Cannon, E. Ohman, 2004 .

Rethinking Composite End Points in Clinical Trials: Insights From Patients and Trialists

J. Spertus, P. Chan, D. Cohen, 2014, Circulation.

Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.

G. Stone, F. Asch, W. Abraham, 2022, Journal of the American College of Cardiology.

STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.

J. Carroll, M. Mack, J. Bavaria, 2020, The Annals of thoracic surgery.

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).

M. Mack, J. Bavaria, L. Svensson, 2012, Journal of the American College of Cardiology.

Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

D. Cohen, M. Hardy, J. Mackay-Wiggan, 2003, Journal of the American Academy of Dermatology.

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Eric Peterson, David A Morrow, David J Cohen, 2006, Journal of the American College of Cardiology.

How to Define a Poor Outcome After Transcatheter Aortic Valve Replacement: Conceptual Framework and Empirical Observations From the Placement of Aortic Transcatheter Valve (PARTNER) Trial

M. Mack, J. Spertus, A. Kirtane, 2013, Circulation. Cardiovascular quality and outcomes.

Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial.

C. Don, M. Mack, L. Svensson, 2015, The Annals of thoracic surgery.

Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.

J. Carroll, J. Bavaria, J. Squiers, 2021, Journal of the American College of Cardiology.

Hospital resources consumed in treating complications associated with percutaneous coronary interventions.

D. Cohen, E. Becker, S. Culler, 2006, The American journal of cardiology.

Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis

D. Cohen, D. Cutlip, S. Rinfret, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.

Sean M. O'Brien, F. Harrell, D. Mark, 2020, The New England journal of medicine.

Integrating Quality of Life and Survival Outcomes Cardiovascular Clinical Trials.

Laura A. Hatfield, Jacob V. Spertus, J. Spertus, 2019, Circulation. Cardiovascular quality and outcomes.

Economic Impact of Angina After an Acute Coronary Syndrome: Insights From the MERLIN-TIMI 36 Trial

E. Braunwald, D. Morrow, P. Chan, 2009, Circulation. Cardiovascular quality and outcomes.

L. Svensson, M. Leon, S. Kapadia, 2011, Circulation.

Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.

J. Leipsic, M. Mack, M. Leon, 2021, Journal of the American College of Cardiology.

Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low-Risk Patients With Severe Aortic Stenosis

J. Webb, D. Cohen, H. Wijeysundera, 2020, Circulation.

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

J. Leipsic, M. Mack, M. Leon, 2020, Circulation.

Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.

M. Mack, M. Leon, S. Kapadia, 2019, Journal of the American College of Cardiology.

Interpreting the results of cost-effectiveness studies.

D. Cohen, M. Reynolds, D. Cohen, 2008, Journal of the American College of Cardiology.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

D. Adams, J. Popma, S. Arnold, 2015, JACC. Cardiovascular interventions.

Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis.

Samin K. Sharma, S. Pocock, G. Dangas, 2020, Journal of the American College of Cardiology.

Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.

J. Spertus, D. Cohen, A. Chhatriwalla, 2015, American heart journal.

Martin B Leon, David J Cohen, M. Leon, 2012, Journal of the American College of Cardiology.

Quality of life among patients with severe aortic stenosis

A. Bogers, D. Cohen, A. Kappetein, 2012, Netherlands Heart Journal.

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

P. Serruys, M. Morice, D. Cohen, 2017, Journal of the American College of Cardiology.

Origin of the left main coronary artery from the "non-coronary" sinus of Valsalva.

D. Baim, D. Cohen, D. Kim, 1991, Catheterization and cardiovascular diagnosis.

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.

E. Topol, W. Desmet, V. Rajagopal, 2006, American heart journal.

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.

Samin K. Sharma, S. Pocock, P. Serruys, 2021, JACC. Cardiovascular interventions.

Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents

Sunil V. Rao, M. Price, S. Pocock, 2020, Circulation. Cardiovascular interventions.

M. Mack, N. Weissman, E. Tuzcu, 2022 .

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

J. Kaufman, S. Goldhaber, M. Jaff, 2020, Journal of vascular surgery. Venous and lymphatic disorders.

Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.

M. Weinstein, D. Baim, D. Cohen, 1993, Journal of the American College of Cardiology.

Ticagrelor With or Without Aspirin After Complex PCI

Samin K. Sharma, S. Pocock, G. Dangas, 2020 .

Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.

H. Miyata, J. Spertus, J. Rumsfeld, 2016, Journal of the American College of Cardiology.

Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation.

M. Mack, G. Stone, W. Abraham, 2021, JACC. Heart failure.

Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.

D. Cohen, M. Reynolds, K. Ho, 2003, American heart journal.

Treatment of diffuse coronary lesions: a time for randomized trials.

H. Dauerman, D. Cohen, D. Cohen, 1999, American heart journal.

Association Between Preoperative Myocardial Perfusion Imaging and Cardiac Events after Elective Noncardiac Surgery

Seung‐Jung Park, Young-Hak Kim, Duk‐Woo Park, 2023, medRxiv.

Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.

H. Dauerman, D. Baim, D. Cohen, 1998, Journal of the American College of Cardiology.

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice.

Sharon-Lise T Normand, Laura Mauri, John A Spertus, 2012, Archives of internal medicine.

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).

E. Topol, T. Henry, A. Lincoff, 2005, The American journal of cardiology.

Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).

G. Stone, D. Cohen, M. Reynolds, 2012, The American journal of cardiology.

Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.

Laura Mauri, Thomas Gaziano, David J Cohen, 2008, Journal of the American College of Cardiology.

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

W. Little, R. Applegate, M. Kutcher, 2011 .

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Lynn A. Sleeper, David J. Cohen, Valentin Fuster, 2013, Circulation.

In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design.

D. Baim, D. Cohen, J. Carrozza, 1999, Circulation.

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.

Hyun-Jae Kang, Young-Bae Park, Si-Hyuck Kang, 2014, European heart journal.

Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes: Insights From the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry

E. DeLong, S. Normand, C. Cannon, 2005, Circulation.

Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.

Samin K. Sharma, T. Henry, M. Krucoff, 2022, JACC. Cardiovascular interventions.

Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.

Samin K. Sharma, S. Pocock, M. Krucoff, 2021, JACC. Cardiovascular interventions.

Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2017, Journal of the American College of Cardiology.

Admission to hospitals with on-site cardiac catheterization facilities :impact on long-term costs and outcomes.

H. Krumholz, J. Chen, M. Radford, 1998, Circulation.

Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2006, Journal of the American College of Cardiology.

The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.

Sunil V. Rao, L. Mauri, J. Lasala, 2019, American heart journal.

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

R. Virmani, G. Stone, A. Finn, 2021, Circulation.

Clinical and Economic Outcomes of Liberal Versus Selective Drug-Eluting Stent Use: Insights From Temporal Analysis of the Multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, E. Mahoney, N. Kleiman, 2011, Circulation.

CORONARY ARTERY DISEASE Original Studies In-Hospital and One Year Outcomes with Drug-Eluting Versus Bare Metal Stents in Large Native Coronary Arteries: A Report From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry

Jay A. Montgomery, N. Kleiman, D. Cohen, 2013 .

An evidence-based approach to the use of drug-eluting stents in clinical practice.

L. Mauri, D. Cohen, R. Kuntz, 2004, The American heart hospital journal.

Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the ‘real world’

Brett G. Sylvia, A. Jeremias, A. Kirtane, 2008, Coronary artery disease.

Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.

Samin K. Sharma, M. Krucoff, G. Dangas, 2021, European heart journal.

Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry

S. Pocock, T. Henry, M. Krucoff, 2019, Thrombosis and Haemostasis.

Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention

D. Cohen, Hyo‐Soo Kim, Hyun-Jae Kang, 2019, Thrombosis and Haemostasis.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS

S. Pocock, T. Henry, M. Krucoff, 2019, Circulation. Cardiovascular quality and outcomes.

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

S. Pocock, T. Henry, M. Krucoff, 2018, Circulation. Cardiovascular interventions.

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2017, JACC. Cardiovascular interventions.

Comparison of Clinical Interpretation With Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemporary Practice: The Assessing Angiography (A2) Project

M. Walsh, J. Elmore, W. Weaver, 2013, Circulation.

D. Cohen, E. Armstrong, E. Magnuson, 2021, Journal of medical economics.

Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.

M. Mack, E. Tuzcu, L. Svensson, 2018, Journal of the American College of Cardiology.

Association Between Diastolic Dysfunction and Health Status Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.

J. Spertus, S. Arnold, D. Cohen, 2019, JACC. Cardiovascular interventions.

Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment.

D. Baim, D. Cohen, C. Gibson, 1993, Journal of the American College of Cardiology.

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

D. Cohen, W. Little, R. Applegate, 2011, Circulation. Cardiovascular quality and outcomes.

Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.

Samin K. Sharma, S. Pocock, E. Ohman, 2021, JAMA cardiology.

TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.

B. Iung, D. Cohen, R. Puri, 2016, European heart journal.

Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).

M. Mack, A. Kirtane, M. Leon, 2015, The American journal of cardiology.

In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

M. Pencina, S. Goldberg, V. Novack, 2009, JACC. Cardiovascular interventions.

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.

B. Gersh, S. Pocock, P. Serruys, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Short- and Intermediate-Term Clinical Outcomes From Direct Myocardial Laser Revascularization Guided by Biosense Left Ventricular Electromechanical Mapping

R. Hendel, R. Bonow, J. Moses, 2000, Circulation.

Carotid stenting versus carotid endarterectomy: how relevant are quality of life and individual adverse events?

D. Cohen, J. Stolker, D. Cohen, 2012 .

L. Goldstein, T. Brott, G. Howard, 2011, Journal of the American College of Cardiology.

Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke.

B. McNeil, P. Wolf, E. DeLong, 2000, Circulation.

Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke

B. McNeil, P. Wolf, E. DeLong, 2000, Stroke.

Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention

M. Pencina, N. Kleiman, D. Cohen, 2012, Journal of Thrombosis and Thrombolysis.

1-Year Outcomes following Bioprosthetic Valve Fracture to Facilitate Valve-in-Valve Transcatheter Aortic Valve Replacement

E. Tseng, J. Webb, B. Whisenant, 2021 .

Bioprosthetic Valve Remodeling of Trifecta Surgical Valves to Facilitate Valve-in-Valve TAVR

D. Dvir, D. Cohen, K. Allen, 2020 .

Complications of Bioprosthetic Valve Fracture as an Adjunct to Valve-in-Valve TAVR

D. Dvir, B. Whisenant, D. Cohen, 2019, Structural Heart.

Is Bioprosthetic Valve Fracture Beneficial for Patients with Larger Surgical Valves Undergoing Valve in Valve TAVR?

D. Cohen, K. Allen, A. Chhatriwalla, 2018, Current Cardiology Reports.

Valve-in-valve TAVR using the SAPIEN 3 transcatheter heart valve: still plagued by patient-prosthesis mismatch.

T. Feldman, D. Cohen, J. Saxon, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioprosthetic Valve Fracture During Valve-in-valve TAVR: Bench to Bedside.

D. Cohen, K. Allen, A. Chhatriwalla, 2017, Interventional cardiology.

Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement

D. Dvir, D. Cohen, K. Allen, 2017, Circulation. Cardiovascular interventions.